EDGAR Filing Documents for 0001615774-16-006923

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001615774-16-006923

Filing Date

2016-08-22

Accepted

2016-08-22 16:44:19

Documents

Period of Report

2016-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-Q	s103965_10q.htm	10-Q	458304
2	EXHIBIT 31.1	s103965_ex31-1.htm	EX-31.1	9769
3	EXHIBIT 31.2	s103965_ex31-2.htm	EX-31.2	9727
4	EXHIBIT 32.1	s103965_ex32-1.htm	EX-32.1	4310
5	EXHIBIT 32.2	s103965_ex32-2.htm	EX-32.2	4264
6	GRAPHIC	tlogo.jpg	GRAPHIC	8609
	Complete submission text file	0001615774-16-006923.txt		4127263

Data Files

Seq	Description	Document	Type	Size
7	XBRL INSTANCE FILE	cttc-20160630.xml	EX-101.INS	824943
8	XBRL SCHEMA FILE	cttc-20160630.xsd	EX-101.SCH	42373
9	XBRL CALCULATION FILE	cttc-20160630_cal.xml	EX-101.CAL	53480
10	XBRL DEFINITION FILE	cttc-20160630_def.xml	EX-101.DEF	267879
11	XBRL LABEL FILE	cttc-20160630_lab.xml	EX-101.LAB	295269
12	XBRL PRESENTATION FILE	cttc-20160630_pre.xml	EX-101.PRE	310192

Mailing Address 1375 KINGS HIGHWAY EAST FAIRFIELD CT 06824

Business Address 1375 KINGS HIGHWAY EAST FAIRFIELD CT 06824 (203) 368-6044

CALMARE THERAPEUTICS Inc (Filer) CIK: 0000102198 (see all company filings)